A Pragmatic Assessment of Influenza Vaccine Effectiveness in the DoD

Running, not enrolling · Phase 4

Conditions studied: Influenza, Influenza-like Illness, Influenza Vaccines

In brief

A total of 18,000 eligible subjects (or 6,000 subject distributed evenly between the 3 study arms) will be enrolled. Eligible subjects will be randomized in 1:1:1 (cell-culture-based vaccine, the recombinant vaccine, or the egg-based vaccine) over four influenza seasons (2018-2019, 2019-2020, 2020-2021, and 2021-2022).

Key facts

Study ID
NCT03734237
Run by
Henry M. Jackson Foundation for the Advancement of Military Medicine
People needed
15448
Starts
2018-11-06
Expected to finish
2026-06-30
Last updated by the study team
2026-04-02

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.